18754841

Source:http://linkedlifedata.com/resource/pubmed/id/18754841

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013058, umls-concept:C0031336, umls-concept:C0034037, umls-concept:C0332120, umls-concept:C0700287, umls-concept:C0879626, umls-concept:C1511726, umls-concept:C1553890, umls-concept:C1704324, umls-concept:C2603343
pubmed:issue	6
pubmed:dateCreated	2008-11-26
pubmed:abstractText	To investigate whether adverse effects data for the sponsor's product are presented more favourably in pharmaceutical industry-funded studies than in non-industry-funded studies.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-10657348, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-10968436, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-11463662, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-12357091, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-12775614, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-12928469, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-15161896, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-15545678, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-15582059, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-15937056, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-17161750, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-17550302, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-17919992, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-17954797, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-18199864, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-18413874, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-18461146, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-8285810, http://linkedlifedata.com/resource/pubmed/commentcorrection/18754841-9420342
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7503323
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1365-2125
pubmed:author	pubmed-author:GolderSuS, pubmed-author:LokeYoon KYK
pubmed:issnType	Electronic
pubmed:volume	66
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	767-73
pubmed:dateRevised	2010-9-21
pubmed:meshHeading	pubmed-meshheading:18754841-Clinical Trials as Topic, pubmed-meshheading:18754841-Drug Industry, pubmed-meshheading:18754841-Drug Toxicity, pubmed-meshheading:18754841-Female, pubmed-meshheading:18754841-Financing, Organized, pubmed-meshheading:18754841-Humans, pubmed-meshheading:18754841-Male, pubmed-meshheading:18754841-Meta-Analysis as Topic, pubmed-meshheading:18754841-Publication Bias, pubmed-meshheading:18754841-Risk Assessment
pubmed:year	2008
pubmed:articleTitle	Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?
pubmed:affiliation	CRD, University of York, York and School of Medicine, University of East Anglia, Norwich, UK. spg3@york.ac.uk
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't